Global Rabies Diagnostics Market
Veterinary Healthcare

Rabies Diagnostics Market Projected at $2.31 Billion by 2029 | Strategic Insights and Forecast Data

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Rabies Diagnostics Market Size Changed, over the years?

The size of the rabies diagnostics market has seen significant growth in the past few years. It is expected to increase from $1.68 billion in 2024 to $1.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. The growth during the historical period can be credited to factors such as globalization and travel trends, adoption of a one health approach, development of regulatory standards, advancements in animal testing, and environmental impacts.

How Much Will the Rabies Diagnostics Market Be Worth in 2029?

In the coming years, the rabies diagnostics market is set to experience substantial growth, expanding to a projected value of $2.31 billion by 2029 with a compound annual growth rate of 6.7%. This growth within the forecast period is largely due to factors such as rising instances of rabies, environmental impacts, cost-effectiveness, research and development efforts, and increasing surveillance needs. Further, the forecast period will see a rise in government-led initiatives and vaccination programs, increased globalization and travel, adoption of the ‘one health’ approach, public health worries, and advancements in remote and point-of-care diagnostics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8476&type=smp

Which is the Largest Company in the Rabies Diagnostics Market?

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.

What Are the Main Market Drivers in the Rabies Diagnostics Industry?

The escalating incidence of rabies is projected to enhance the expansion of the rabies diagnostics market. Rabies is an avoidable viral disease majorly transmitted through the bite of a rabid animal. The rabies virus assaults the central nervous systems of mammals, leading to ultimate brain damage and death. Rabies diagnostics are utilized to identify the rabies virus in humans and animals through various diagnostic tests and procedures. Moreover, the growing instances of infectious diseases transmitted by animals have encouraged the need for rabies diagnostics. For instance, according to the Government of Canada, a federal authority based in Canada, in their January 2023 report, 135 rabies samples were submitted in October 2022 and 159 samples in November 2022. Consequently, the escalating incidence of rabies will fuel the rabies diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8476&type=smp

How Is the Rabies Diagnostics Market Segments Structured?

The rabies diagnostics market covered in this report is segmented –

1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests

2) By Technology: ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies

3) By End-User: Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users

Subsegments:

1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)

2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA): Western Blotting

3) By Amplification Methods: Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)

4) By Histologic Examination: Microscopic Examination, Tissue Staining Techniques

5) By Serology Tests: Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)

What Strategic Trends Are Transforming the Rabies Diagnostics Market?

The emergence of product innovation is a notable trend being adopted in the rabies diagnostics market. Pharmaceutical manufacturers worldwide are utilizing innovative testing techniques born out of analytical chemistry to offer precise, cost-efficient analytical solutions. These newly developed testing products are effectively incorporated into conventional sample testing protocols. For instance, the CFX Duet Real-Time PCR system was launched by Bio-Rad Laboratories Inc., a U.S based company specializing in technology product development and manufacturing, in May 2022. This clinical diagnostic device is designed to assist researchers in creating singleplex and duplex quantitative PCR (qPCR) tests. Its distinctive characteristics offer enhanced thermal performance and incorporate proprietary optical shuttle systems and thermal gradient features for optimization.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the Rabies Diagnostics Market?

North America was the largest region in the rabies diagnostics market in 2024. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8476

This Report Delivers Insight On:

1. How big is the rabies diagnostics market, and how is it changing globally?

2. Who are the major companies in the rabies diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the rabies diagnostics market right now?

4. Which products or customer segments are growing the most in the rabies diagnostics market?

5. What factors are helping or slowing down the growth of the rabies diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model